CAS 1113044-49-7

FIT-039

Description:

FIT-039, with the CAS number 1113044-49-7, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is characterized by its specific molecular structure, which includes functional groups that contribute to its biological activity. FIT-039 is known to act as a selective inhibitor, targeting specific pathways in cellular processes, which may have implications in treating various diseases. The compound's solubility, stability, and reactivity are influenced by its molecular configuration, making it suitable for further research and development. Additionally, its pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion, are critical for understanding its efficacy and safety profile in potential clinical applications. As with many chemical substances, ongoing studies aim to elucidate its mechanism of action and optimize its therapeutic potential while assessing any associated risks or side effects.

Formula: C₁₇H₁₈FN₃S

Synonyms:

• FIT-039
• 4-Pyridinecarbothioamide, N-[5-fluoro-2-(1-piperidinyl)phenyl]-
• (FIT039)
• N-[5-Fluoro-2-(1-piperidinyl)phenyl]-4-pyridinecarbothioamide
• N-(5-fluoro-2-(piperidin-1-yl)phenyl)pyridine-4-carbothioamide

FIT-039

CAS: 1113044-49-7

FIT-039

Purity: ≥98%

Molecular weight: 315.41g/mol

Ref: 54-BUP10857

FIT-039

CAS: 1113044-49-7

FIT-039 is a selective and ATP-competitive, orally active inhibitor of CDK9( IC50 : 5.8 μM;CDK9/cyclin T1).

Formula: C₁₇H₁₈FN₃S

Purity: 98.61%

Color and Shape: Solid

Molecular weight: 315.41

Ref: TM-T8972

FIT-039

CAS: 1113044-49-7

FIT-039 is a drug that inhibits the sodium taurocholate cotransporting polypeptide (NTCP) in human cells. It prevents the absorption of bile salts from the gut, which leads to an increase in the concentration of bile acids and cholesterol in the blood. FIT-039 has been shown to have anti-cancer properties, as well as inhibitory effects on viruses such as hepatitis C virus, papilloma virus, and herpes simplex virus. This drug also has been shown to have an inhibitory effect on cervical cancer cells with curcumin analogs. FIT-039 is not active against other types of cancer cells including lung cancer, prostate cancer, breast cancer, or colorectal cancer.

Formula: C₁₇H₁₈FN₃S

Purity: Min. 95%

Molecular weight: 315.4 g/mol

Ref: 3D-NUB04449